SCHEMBL3847752

SCHEMBL3847752

CC(Cc1ccccc1)NCF

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 14/20 0.68
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
TSHR P16473 1/20 0.61
TAAR1 Q96RJ0 2/20 0.61
SLC18A2 Q05940 1/20 0.61
ADRB2 P07550 1/20 0.58
ADRB1 P08588 1/20 0.58
HTR1A P08908 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
DRD2 P14416 1/20 0.58
ADRA2B P18089 1/20 0.58
ADRA2C P18825 1/20 0.58
CNR1 P21554 1/20 0.58
SLC6A2 P23975 1/20 0.58
HTR2A P28223 1/20 0.58
SLC6A4 P31645 1/20 0.58
MC4R P32245 1/20 0.58
ADRA1A P35348 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15887532 0.84 SIGMAR1 (0.70) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL13181363 0.84 SIGMAR1 (0.70) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL29059547 0.83 SIGMAR1 (0.81) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
N-Benzylamphetamine SCHEMBL2795222 0.81 SIGMAR1 (1.00) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
Etilamfetamine SCHEMBL16866783 0.81 SIGMAR1 (1.00) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
N-Benzylamphetamine SCHEMBL2451256 0.81 SIGMAR1 (1.00) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
Etilamfetamine SCHEMBL309802 0.81 SIGMAR1 (1.00) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
Etilamfetamine SCHEMBL162316 0.81 SIGMAR1 (1.00) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
N-Benzylamphetamine SCHEMBL2798189 0.81 SIGMAR1 (1.00) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3888366 0.79 SIGMAR1 (0.68) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682944-B2 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors PIRAMAL IMAGING SA (CH) 2017-06-20 US disclosed
EP-2129369-A1 TREATMENT OF ADHD Gosforth Centre (Holdings) Pty Ltd (AU) 2009-12-09 EP disclosed
WO-2008095253-A1 TREATMENT OF ADHD GOSFORTH CENTRE (HOLDINGS) PTY LTD (AU) 2008-08-14 WO disclosed
US-5589513-A TREATMENT OF NEURODEGENERATIVE DISEASES; MONOAMINE OXIDASE INHIBITOR AND UPTAKE INHIBITOR CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1996-12-31 US disclosed